
Article
What are lymphoma and myeloma?
Lymphoma and myeloma are both types of blood cancer that develop when white blood cells gr...
Dr Shenbagaram Kasivisvanathan is a consultant haematologist and haemato-oncologist based in Portsmouth, practicing at Portsmouth Hospitals University NHS trust and Spire Portsmouth Hospital. He is recognised for his expertise in the diagnosis and management of complex blood cancers, particularly lymphoma, myeloma, myeloproliferative neoplasms and leukaemia, alongside a wide range of non-malignant haematological disorders including anaemia, thrombocytopaenia (low platelets), blood clots etc
He completed his MBBS in 2009 at Pondicherry University followed by an MD in Internal Medicine, before undertaking specialist haematology training in the East of England, including Basildon and Cambridge University Hospitals NHS Trust. He went on to complete advanced subspecialist training in bone marrow transplantation and cellular therapies, including CAR-T cell therapy, at Cambridge University Hospitals, reflecting his focus on modern, targeted treatments in haematological malignancies. He was awarded MRCP in 2017 and FRCPath in 2024, marking his progression to consultant-level expertise in clinical haematology.
In his NHS consultant role at Portsmouth Hospitals University NHS Trust, Dr Kasivisvanathan provides specialist care for patients with both acute and chronic haematological conditions, with a strong emphasis on personalised treatment strategies for blood cancers. He is actively involved in multidisciplinary care pathways and contributes to the advancement of haematology services within the NHS, including partaking in the clinical trials. Alongside his clinical practice, he is engaged in teaching and training junior doctors, reflecting his commitment to developing the next generation of haematology specialists.

Medical insurances accepted